Pacific Edge Announces Agreement with Northern Health in Australia
09th December 2021

Pacific Edge is pleased to announce today that it has reached its first commercial agreement of scale in Australia with Northern Health, a major provider of healthcare and hospital services to Melbourne’s rapidly growing outer northern suburbs. Read More

Cxbladder on the Podium at the Annual SUO Meeting in the US
08th December 2021

Late last week, at the Annual Meeting of the Society of Urologic Oncology (SUO) in Orlando USA, urologists at UCSF presented their findings on the use of Cxbladder Monitor (CxbM) in a real-world setting for managing patients during COVID-19. Read More

Journal of Urology Publishes Outperformance of Cxbladder in US Covid-19 Setting
18th August 2021

The American Urological Association’s (AUA) Journal of Urology has published a real world lookback highlighting the clinical utility of Cxbladder in a Covid-19 setting for the management of patients outside the clinic. Read More

Taranaki District Health Board Adopts Full Suite of Cxbladder Tests
03rd August 2021

Pacific Edge is pleased to confirm that the company has reached commercial agreement with the Taranaki District Health Board for the use of Cxbladder products across the clinical pathway in the detection, management, and monitoring of bladder cancer patients. Read More

Combined Use of Cxbladder Products Shows Significant Outperformance
08th July 2021

A pivotal, peer-reviewed paper, accepted for publication in the Journal of Urology, demonstrates the significant clinical and patient benefits from the use of a combination of Cxbladder products to correctly identify haematuria patients, who have urothelial cancer (UC) and also, further segregate those patients with high-impact tumours (HIT) requiring priority investigation. Read More

Cxbladder Continues To Win Over NZ Public Healthcare Providers
07th July 2021

Pacific Edge is pleased to advise that it has reached a commercial agreement with Northland District Health Board (DHB) and Northland’s primary health entity Mahitahi Hauora for the use of Cxbladder products. Read More

United Healthcare Issues Positive Coverage Decision for Cxbladder
09th April 2021

Pacific Edge is pleased to advise that its Cxbladder bladder cancer diagnostic tests are now covered by United Healthcare, the largest healthcare group in the US. Read More

Pacific Edge Concludes Commercial Agreement With Facey Medical Group in US
31st March 2021

Pacific Edge Limited has concluded a commercial agreement with Facey Medical Group, a physician owned medical group in California. The agreement covers the use of Cxbladder Detect and Cxbladder Monitor for Facey Medical Group patients. Read More